SEC Filings

Form PRE 14A
KERYX BIOPHARMACEUTICALS INC filed this Form PRE 14A on 03/27/2017
Document Outline
Entire Document (723.4 KB)
Subdocument 1 - PRE 14A - PRE 14A
Page 1 - UNITED STATES
Page 2 - KERYX BIOPHARMACEUTICALS, INC.
Page 3 - KERYX BIOPHARMACEUTICALS, INC.
Page 4 - YOUR VOTE IS IMPORTANT!
Page 5 - KERYX BIOPHARMACEUTICALS, INC.
Page 6 - Table of Contents
Page 7 - N/A
Page 8 - QUESTIONS AND ANSWERS
Page 9 - Q. How do I vote?
Page 10 - Q. How are votes counted?
Page 11 - Q. How will the outcome of the non-binding advisory vote to approve the frequency of holding an advi
Page 12 - CORPORATE GOVERNANCE
Page 13 - John P. Butler
Page 14 - Daniel P. Regan
Page 15 - Jodie P. Morrison.
Page 16 - Compensation Committee
Page 17 - Research and Development Committee
Page 18 - N/A
Page 19 - Code of Ethics
Page 20 - INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FEES AND OTHER MATTERS
Page 21 - N/A
Page 22 - REPORT OF THE AUDIT COMMITTEE
Page 23 - OUR EXECUTIVE OFFICERS
Page 24 - Christine Carberry
Page 25 - COMPENSATION DISCUSSION AND ANALYSIS
Page 26 - Determining Executive Compensation
Page 27 - Benchmarking and Peer Group
Page 28 - Base Salary
Page 29 - Annual Cash Incentive Awards
Page 30 - Special Bonus Awards (milestone equity awards)
Page 31 - All NEOs.
Page 32 - All NEOs.
Page 33 - Severance and Change-of Control Benefits
Page 34 - RISK ASSESSMENT OF COMPENSATION PROGRAMS
Page 35 - EXECUTIVE COMPENSATION
Page 36 - Grants of Plan-Based Awards for Fiscal Year 2016
Page 37 - Narrative to Summary Compensation Table and Grants of Plan-Based Awards for Fiscal Year 2016
Page 38 - Plan-Based Awards
Page 39 - Outstanding Equity Awards at 2016 Fiscal Year End
Page 40 - N/A
Page 41 - N/A
Page 42 - Option Exercises and Stock Vested in Fiscal Year 2016
Page 43 - Gregory P. Madison
Page 44 - Termination Other than for Cause; Termination for Good Reason
Page 45 - Restrictive Covenants
Page 46 - Termination Other than for Cause; Termination for Good Reason
Page 47 - DIRECTOR COMPENSATION
Page 48 - N/A
Page 49 - N/A
Page 50 - COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
Page 51 - Related Person Transactions
Page 52 - STOCK OWNERSHIP OF OUR DIRECTORS, EXECUTIVE OFFICERS, AND 5% BENEFICIAL OWNERS
Page 53 - N/A
Page 54 - PROPOSAL ONE:
Page 55 - PROPOSAL TWO:
Page 56 - PROPOSAL THREE:
Page 57 - PROPOSAL FOUR:
Page 58 - PROPOSAL FIVE:
Page 59 - The Board Approved the Ratification of the May 2016 Certificate of Amendment
Page 60 - Filing of a Certificate of Validation
Page 61 - PROPOSAL SIX:
Page 62 - ADDITIONAL INFORMATION
Page 63 - Annex A
Page 64 - RESOLVED, FURTHER,
Page 65 - Exhibit A to Board Resolutions
Page 66 - EXHIBIT A TO CERTIFICATE OF VALIDATION
Page 67 - Annex B
Page 68 - N/A
Page 69 - Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: